00:01
Let’s talk about management of hepatitis B.
00:04
We have interferons for hepatitis B.
00:07
We have peginterferon,
we have interferon alpha.
00:10
That's important.
00:11
Please memorize the alpha for hepatitis B.
00:14
And limited duration of therapy,
high side effect burden is what you’re worried about,
especially with interferons.
00:23
Management continues and we have antiviral drugs
such as Lamivudine, resistance oftentimes seen.
00:31
We have Entecavir,
Adefovir,
Tenofovir.
00:36
Stop there.
00:37
You'll notice, we have the suffix, -vir, -vir, -vir.
00:41
Your focus should be on viral hepatitis, specifically B.
00:46
And we have -vir, virus.
00:50
Usually indefinite therapy concern.
00:53
But the only thing is you’re worried about
resistance in this patient with hepatitis B.
00:57
Antiviral drugs that you want to be familiar with.
01:02
Obviously, your focus should also be on prevention.
01:06
Let’s begin the vaccination.
01:07
The vaccination therapy and the regimen
is something that you want to be
very familiar with coming off of immunology.
01:14
If you're not, it will be a good time to go back
and make sure that you take a look at
vaccination regimen for hepatitis B,
specifically, please, perinatal exposure,
universal vaccination for all children.
01:28
Now, whatever your personal belief would be on vaccination,
at this point, you keep that to yourself.
01:34
I highly recommend that
Healthcare workers,
hemodialysis patients, men who have sex with men,
IV drug abusers, persons with recent exposure
and patients with chronic liver disease.
01:46
This is your population in which you need to make sure
that you prevent hepatitis B from developing.